Immunomodulatory Peptides for Tumor Treatment
Advanced Healthcare Materials · 2025-02 · 14 (5)
DOI: 10.1002/adhm.202400512 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 04.05.2024. Verfasst von Yang Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, Universi…. Hauptthemen laut MEDLINE: Peptides, Neoplasms, Immunomodulation, Immunologic Factors. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 204 Literaturangaben. Gefördert von: Key R & D Program of Hunan province, Hunan Provincial Natural Science Foundation, Hunan Science and Technology Innovation Leading Talent.
Abstract (Originalsprache)
Peptides exhibit various biological activities, including biorecognition, cell targeting, and tumor penetration, and can stimulate immune cells to elicit immune responses for tumor immunotherapy. Peptide self‐assemblies and peptide‐functionalized nanocarriers can reduce the effect of various biological barriers and the degradation by peptidases, enhancing the efficiency of peptide delivery and improving antitumor immune responses. To date, the design and development of peptides with various functionalities have been extensively reviewed for enhanced chemotherapy; however, peptide‐mediated tumor immunotherapy using peptides acting on different immune cells, to the knowledge, has not yet been summarized. Thus, this work provides a review of this emerging subject of research, focusing on immunomodulatory anticancer peptides. This review introduces the role of peptides in the immunomodulation of innate and adaptive immune cells, followed by a link between peptides in the innate and adaptive immune systems. The peptides are discussed in detail, following a classification according to their effects on different innate and adaptive immune cells, as well as immune checkpoints. Subsequently, two delivery strategies for peptides as drugs are presented: peptide self‐assemblies and peptide‐functionalized nanocarriers. The concluding remarks regarding the challenges and potential solutions of peptides for tumor immunotherapy are presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China.
- Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, 410013, China.
ORCID-Profile: Hua Wei
Förderung
- Key R & D Program of Hunan province
- Hunan Provincial Natural Science Foundation
- Hunan Science and Technology Innovation Leading Talent
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Song, Y., Lei, L., Cai, X., Wei, H., & Yu, C. Y. (2025). Immunomodulatory Peptides for Tumor Treatment. Advanced Healthcare Materials, 14(5). https://doi.org/10.1002/adhm.202400512
Vancouver
Song Y, Lei L, Cai X, Wei H, Yu CY. Immunomodulatory Peptides for Tumor Treatment. Advanced Healthcare Materials. 2025;14(5). doi:10.1002/adhm.202400512
BibTeX
@article{Song2025,
author = {Song, Yang and Lei, Longtianyang and Cai, Xingyu and Wei, Hua and Yu, Cui-Yun},
title = {Immunomodulatory Peptides for Tumor Treatment},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {5},
doi = {10.1002/adhm.202400512}
}
EUVIMED